Virus testing Stocks ( $CODX, $FLGT, $ALST, $LH

11 Nov 2020, Wednesday

The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus vaccine candidate, noting that it registered a 90% efficacy rate with no complications in its phase 3 study involving over 43K patients. But still Covid-19 testing must continue. Stocks took flight, bonds dropped, and small-caps and cyclicals massively outperformed tech stocks as the prospect of a reopening of…

Continue Reading